“Efficacy, Safety and Tolerability of the Once-Daily 10 Cm² Rivastigmine Patch Formulation in the Patients With Dementia (with Probable Alzheimer’s Disease)”. Bangladesh Journal of Neuroscience 29, no. 1 (January 31, 2013): 5–14. Accessed July 3, 2026. https://banglajol.info/index.php/BJN/article/view/56165.